Stay updated on Pembrolizumab in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a Locations section listing Pennsylvania and Texas as study sites, replacing the former Pennsylvania Locations and Texas Locations entries.
    Difference
    0.4%
    Check dated 2025-12-23T13:41:58.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now displays a new revision label, v3.3.2, replacing v3.3.1, indicating a minor update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:46:49.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Publications note wording updated to indicate items are automatically filled from PubMed. Revision tag updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:49:08.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding and related operating-status information was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:10:53.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    No significant content changes detected between the screenshots; the page content remains the same aside from minor UI updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:23:57.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    4%
    Check dated 2025-10-05T10:29:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page.